This unsolicited device case from united states was received on (b)(4) 2014 from a consumer (patient's sister).This case concerns a (b)(6) male patient who died whilst receiving treatment with synvisc.No past drugs, medical history, concomitant medications or concurrent condition was reported.On an unknown date in (b)(6) 2012, the patient initiated treatment with 2 ml, synvisc injection (route, frequency, indication, batch/lot number and expiration date: not provided) into unspecified knee.On an unknown date in (b)(6) 2013, the patient received synvisc injection.On an unknown date, the patient died due to unspecified cause.It was unknown whether an autopsy was done.A global pharmaceutical technical complaint (ptc) was initiated and ptc results were pending for the same.
|
Pharmacovigilance comment: sanofi company comment dated (b)(4) 2014: this is an initial case concerning a (b)(6) male patient who passed away while on synvisc therapy.The unknown cause of death, lack of information regarding temporal relationship, patient's underlying concurrent medical conditions and concomitant medications precludes the complete medical assessment of the case.
|